Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | OMO-103 |
| Trade Name | |
| Synonyms | OMO 103|OMO103 |
| Drug Descriptions |
OMO-103 inhibits MYC, potentially leading to decreased tumor cell proliferation (NCI Drug Dictionary). |
| DrugClasses | c-MYC Inhibitor 12 |
| CAS Registry Number | NA |
| NCIT ID | C180503 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Gemcitabine + Nab-paclitaxel + OMO-103 | Gemcitabine Nab-paclitaxel OMO-103 | 0 | 1 |
| OMO-103 | OMO-103 | 0 | 3 |